Back
Open Access

Angiotensin receptor-neprilysin inhibitors in concurrent heart failure with reduced ejection fraction and kidney failure on replacement therapy

Session: Advancing heart failure diagnosis and management: insights from hemodynamics, inflammation, and emerging therapies
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Speaker: Professor J. Youn (Seoul, KR)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Professor Jong-Chan Youn

Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul (Korea (Republic of))
0 follower

4 more presentations in this session

Discrepancy in supine versus upright exercise hemodynamic testing and the impact on the diagnostic performance of H2FPEF and HFA-PEFF scores in patients with unexplained dyspnea

Speaker: Doctor V. kittipibul (Durham, US)

Access
Abstract
Like
Thumbnail

Residual inflammation after myocardial infarction detected by somatostatin receptor PET predicts long-term adverse cardiac remodelling: findings of a parallel-design longitudinal cohort study

Speaker: Doctor A. Corovic (Cambridge, GB)

Access
Abstract
Like
Thumbnail

Cardiac resynchronization therapy: an enabler for GDMT optimization in HFrEF? Data from the Swedish Heart Failure and the Swedish Pacemaker and Implantable Cardioverter-Defibrillator Registries.

Speaker: Doctor D. Tomasoni (Brescia, IT)

Access
Abstract
Like
Thumbnail

Mitral regurgitation in patients with heart failure and reduced ejection fraction and clinical outcomes: Insights from GALACTIC-HF

Speaker: Doctor M. Chimura (Glasgow, GB)

Access
Abstract
Like
Thumbnail

Access the full session

Advancing heart failure diagnosis and management: insights from hemodynamics, inflammation, and emerging therapies

Speakers: Professor J. Youn, Doctor V. kittipibul, Doctor A. Corovic, Doctor D. Tomasoni, Doctor M. Chimura
Access
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources